![]() |
JOURNAL TOOLS |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Estratti |
Permessi |

I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
TUMOR IMMUNOLOGY
Minerva Biotecnologica 1999 December;11(4):319-24
Copyright © 1999 EDIZIONI MINERVA MEDICA
lingua: Inglese
Clinical trials of immunotherapy: active immunotherapy or therapeutic vaccination
Maio M. 1, Parmiani G. 2
1 Advanced Immunotherapy Unit, Centro di Riferimento Oncologico, Istituto Nazionale di Ricovero e Cura a Carattere Scientifico Aviano, Italy; 2 Unit of Immunotherapy of Human Tumors, Istituto Nazionale Tumori, Milan (Italy)
During the recent years, new information obtained from basic immunology and from the use of molecular techniques has advanced our understanding of mechanism of induction of immune response and caused a new wave of studies of active immunotherapy of cancer both at pre-clinical and clincal level. Here we summarize these new findings and illustrate the rationale that has generated a flurry of new approaches which are being translated into clinical protocols. Though many problems have still to be solved, the available studies, which are briefly described, suggest that a clinical benefit could be obtained in metastatic cancer patients vaccinated with appropriate tumor antigens in certain clinical conditions. Altogether, it appears that cancer vaccines can become a valuable additional modality against cancer.